$IVST “Dr. Morris-Irvin has a unique combination of subject matter expertise, experience, and business acumen that make him a perfect leader for this division,” said Innovest CEO, Dan Martin. “And he’s one of the most respected professionals and best people you could ever have the pleasure to know. We expect this division to result in ownership of meaningful intellectual property and other progress, without the significant capital costs of traditional biotech initiatives. His relationships, plans, and creativity tell me we will have an exiting path ahead that we are well equipped to execute, and I am thrilled to get started on it with him at the helm.”
https://finance.yahoo.com/news/innovest-globa...00771.html